Mesalamine Retard Granules (Pellets)

Mesalamine Retard Granules (Pellets)
Product Description

Mesalamine Retard Granules (Pellets) 90% & 95% are high-drug-load modified-release pellets used for the development of oral Mesalamine formulations intended for the management of ulcerative colitis and other approved inflammatory bowel disease indications.

GPT PHARMACEUTICALS PRIVATE LIMITED

  • Country/Region:
    India
  • Founded:
    2009
  • On CPHI since:
    2025
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Other
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)

GPT PHARMACEUTICALS PRIVATE LIMITED

  • Country/Region:
    India
  • Founded:
    2009
  • On CPHI since:
    2025
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Other
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)

More Products from GPT PHARMACEUTICALS PRIVATE LIMITED (4)

  • Esomeprazole Enteric Coated Pellets

    Product Esomeprazole Enteric Coated Pellets

    Esomeprazole Enteric-Coated Pellets are acid-protected multiparticulate pellets designed for delayed release in the intestinal tract. They provide a flexible intermediate for the development of oral dosage forms intended for acid-related gastrointestinal disorders, including GERD and erosive esophagitis.
  • Pancreatin Enteric Coated Pellets

    Product Pancreatin Enteric Coated Pellets

    Pancreatin EC Pellets are enteric-coated pellets containing Pancreatin, a digestive enzyme preparation comprising lipase, amylase, and protease. The enteric coating protects the enzymes from degradation in the acidic gastric environment and enables their release in the duodenum/small intestine, where they ...
  • Pantoprazole Enteric Coated Pellets

    Product Pantoprazole Enteric Coated Pellets

    Pantoprazole Enteric-Coated Pellets are acid-protected pellets designed for delayed release in the intestinal tract. They provide a flexible pharmaceutical intermediate for developing oral dosage forms intended for the management of GERD, erosive esophagitis, and other acid-related gastrointestinal disorders.
  • Phenazopyridine HCl DC Granules

    Product Phenazopyridine HCl DC Granules

    Phenazopyridine HCl DC Granules are ready-to-compress pharmaceutical granules designed for the manufacture of oral tablets. The product provides a convenient direct-compression platform for formulations intended for the symptomatic relief of urinary tract pain, burning, and discomfort.

GPT PHARMACEUTICALS PRIVATE LIMITED resources (2)